Supporting these findings, another study on epigenetic changes in mouse models of NASH confirmed the existence of TREM2+ CD9+ macrophages (corresponding to scar-associated macrophages in humans) localized in the fibrotic niche. The gene discussed is CD9; the disease is metabolic dysfunction-associated steatohepatitis.